Indeed, ABCA1 downregulation has been observed in prostate cancers (141), and suppression of ABCA1 expression by oncogenic mutations or loss-of-function mutation has been linked to an accumulation of mitochondrial cholesterol and malignant cell transformation (142). The gene discussed is ABCA1; the disease is Familial prostate cancer.